Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice-Reference-Cited by-同舟云学术

Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice

Published:2023-05 Issue: Volume:Volume 14 Page:111-126
ISSN:1179-271X
Container-title:Patient Related Outcome Measures
language:en
Short-container-title:PROM

Author:

Campbell Rachel^ORCID,King Madeleine T,Stockler Martin R^ORCID,Lee Yeh Chen,Roncolato Felicia T,Friedlander Michael L

Publisher

Informa UK Limited

Subject

General Medicine

Reference107 articles.

1. Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labelling claims. Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed April 27, 2023.

2. Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology

3. The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis

4. A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs)

5. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer;Gynecologic Oncology;2024-06

2. The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls;Supportive Care in Cancer;2024-01-22